Treatment of Pervasive Developmental Disorders

Details for Australian Patent Application No. 2007313911 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Haas, Magali

Agent Shelston IP

Pub. Number AU-A-2007313911

PCT Pub. Number WO2008/054984

Priority 60/863,595 31.10.06 US

Filing date 15 October 2007

Wipo publication date 8 May 2008

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/054984 Priority application(s): WO2008/054984

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007313927-Aqueous film-forming compositions containing reduced levels of volatile organic compounds

2007313908-A system for detecting and communicating with RFID memory devices